Dr. Valdivia completed her Doctorate of Medicine at Baylor College of Medicine and her psychiatric residency at Boston Medical Center. She pursued advanced post-residency training at Massachusetts General Hospital and McLean Hospital, specializing in neurotherapeutics including electroconvulsive therapy, transcranial magnetic stimulation, and ketamine therapy. Her clinical expertise centers on integrating and applying innovative approaches for complex psychiatric and neurological conditions. 

Dr. Valdivia believes MH² will be a place of hope and empowerment for patients through its dedication to uncovering the metabolic root causes of chronic illness. She is passionate about restoring mitochondrial function through targeted metabolic therapies and prioritizes interventions that support circadian biology and hormone health. She is also committed to leveraging emerging modalities such as photobiomodulation and ketogenic metabolic therapy to optimize patient outcomes.